0000899243-18-017765.txt : 20180622
0000899243-18-017765.hdr.sgml : 20180622
20180622182034
ACCESSION NUMBER: 0000899243-18-017765
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180620
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATRICK DEVAL L
CENTRAL INDEX KEY: 0001053466
STANDARD INDUSTRIAL CLASSIFICATION: AIR TRANSPORTATION, SCHEDULED [4512]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 18915571
MAIL ADDRESS:
STREET 1: BAIN CAPITAL, LLC
STREET 2: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-20
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001053466
PATRICK DEVAL L
C/O GLOBAL BLOOD THERAPEUTICS, INC.
171 OYSTER POINT BLVD, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
42.25
2018-06-20
4
A
0
15000
0.00
A
2028-06-19
Common Stock
15000
15000
D
The shares vest and become exercisable in 12 equal monthly installments, with the first installment on July 20, 2018, subject to the recipient's continued service on the Issuer's Board of Directors. This option is subject to accelerated vesting upon a change of control of the Issuer.
/s/ Lesley Ann Calhoun, as Attorney-in-Fact
2018-06-22